News
The viral content creator tells all about her severe eczema and why she supplements her “from scratch” recipes with Cetaphil.
1d
Sinar Daily on MSNUnder pressure: How your 9 to 5 could be showing up on your skinChronic workplace stress doesn’t just stay bottled up in your headspace. Instead, it manifests physically, particularly ...
2025 — A medical research team has confirmed that ultrafine bubble showers significantly suppress inflammation in mice with atopic dermatitis due to external ... Mar. 12, 2025 — Lupus is an ...
The drug – called brepocitinib – is the centrepiece of the new biotech's R&D pipeline and is already a pair of pivotal trials in patients with dermatomyositis and systemic lupus erythematosus ...
Fate Therapeutics recently announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for the lupus treatment candidate FT819.
May 23, 2024 — Treatment of autoimmune diseases like lupus has long relied on steroids to knock down the immune system, but more targeted therapies are currently undergoing clinical trials.
A new study published in The Journal of the American Heart Association provides insights to improve cardiovascular disease ...
This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Michael S.
Tralokinumab use in patients with head and neck atopic dermatitis was associated with sustained improvements with up to 4 years of treatment.
Racial representation in recent atopic dermatitis trials has largely been representative of the U.S. population. Black individuals should be represented more because of disease prevalence rates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results